EM
Eliana Merle Barclays Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
40
Avg Return
Past Year
Past Year
8.7%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
77.3%
Neutral
20.5%
Negative
2.3%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Financials
Healthcare
Financials
Asset Management
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Initiated
| $923 |
18%
upside
| 1 | +2.2% |
0
%
| 6 Mar ‘26 4 days ago |
|
|
|
Overweight
Maintained
| $105 |
72%
upside
| 2 | +0.53% |
0
%
| 4 Mar ‘26 6 days ago |
|
|
|
Overweight
Maintained
| $56 |
31%
upside
| 2 | -15% |
0
%
| 2 Mar ‘26 8 days ago |
|
|
|
Underweight
Downgraded
| $0.3000 |
46%
downside
| 3 | -40% |
0
%
| 24 Feb ‘26 14 days ago |
|
|
|
Overweight
Maintained
| $607 |
32%
upside
| 2 | -1.3% |
0
%
| 17 Feb ‘26 21 days ago |
|
|
|
Equal-Weight
Initiated
| $31 |
72%
upside
| 1 | – |
–
| 28 Jan ‘26 1 month ago |
|
|
|
Overweight
Initiated
| $59 |
75%
upside
| 1 | +7.5% |
0
%
| 28 Jan ‘26 1 month ago |
|
|
|
Equal-Weight
Initiated
| $8 |
49%
upside
| 1 | +45% |
–
| 28 Jan ‘26 1 month ago |
|
|
|
Overweight
Upgraded
| $119 |
74%
upside
| 1 | -9.4% |
0
%
| 28 Jan ‘26 1 month ago |
|
|
|
Overweight
Initiated
| $66 |
136%
upside
| 1 | -23% |
0
%
| 28 Jan ‘26 1 month ago |
|
|
|
Overweight
Initiated
| $964 |
123%
upside
| 3 | +12% |
0
%
| 28 Jan ‘26 1 month ago |
|
|
|
Overweight
Initiated
| $18 |
182%
upside
| 1 | -7.1% |
0
%
| 28 Jan ‘26 1 month ago |
|
|
|
Overweight
Initiated
| $231 |
61%
upside
| 1 | -12% |
0
%
| 28 Jan ‘26 1 month ago |
|
|
|
Overweight
Initiated
| $342 |
43%
upside
| 2 | +13% |
0
%
| 28 Jan ‘26 1 month ago |
|
|
|
Overweight
Initiated
| $33 |
278%
upside
| 1 | +2.8% |
0
%
| 28 Jan ‘26 1 month ago |
|
|
|
Overweight
Initiated
| $80 |
22%
upside
| 3 | +26% |
0
%
| 28 Jan ‘26 1 month ago |
|
|
|
Equal-Weight
Initiated
| $24 |
20%
upside
| 2 | +21% |
0
%
| 28 Jan ‘26 1 month ago |
|
|
|
Overweight
Initiated
| $527 |
63%
upside
| 3 | +12% |
0
%
| 28 Jan ‘26 1 month ago |
|
|
|
Neutral
Assumed
| $34 |
39%
downside
| 3 | +16% |
0
%
| 7 Jan ‘26 2 months ago |
|
|
|
Buy
Maintained
| $24 |
519%
upside
| 1 | +7.2% |
0
%
| 13 Aug ‘25 6 months ago |
|
|
|
Neutral
Maintained
| $9 | – | 2 | – |
–
| 12 Aug ‘25 7 months ago |
|
|
|
Neutral
Maintained
| $20 |
66%
downside
| 1 | – |
–
| 12 Aug ‘25 7 months ago |
|
|
|
Neutral
Downgraded
| $12 |
32%
downside
| 1 | – |
–
| 21 Jul ‘25 7 months ago |
|
|
|
Buy
Maintained
| $8 |
235%
upside
| 1 | -35% |
0
%
| 15 Jul ‘25 7 months ago |
|
|
|
Neutral
Downgraded
| $5.50 | – | 2 | +54% |
0
%
| 26 Jun ‘25 8 months ago |
|